TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 20 filers reported holding TREVI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,444 | +62.6% | 1,580 | +78.3% | 0.00% | – |
| Q2 2023 | $2,118 | -99.9% | 886 | -99.9% | 0.00% | – |
| Q3 2022 | $2,403,000 | +926.9% | 1,560,125 | +1774.6% | 0.00% | – |
| Q2 2022 | $234,000 | -85.1% | 83,225 | -85.6% | 0.00% | – |
| Q1 2021 | $1,574,000 | +12.8% | 576,500 | 0.0% | 0.00% | – |
| Q4 2020 | $1,395,000 | -56.3% | 576,500 | -27.3% | 0.00% | – |
| Q3 2020 | $3,195,000 | -38.7% | 792,700 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $5,216,000 | +100.0% | 792,700 | 0.0% | 0.00% | – |
| Q1 2020 | $2,608,000 | -12.3% | 792,700 | 0.0% | 0.00% | – |
| Q4 2019 | $2,973,000 | -16.7% | 792,700 | 0.0% | 0.00% | – |
| Q3 2019 | $3,567,000 | -40.0% | 792,700 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $5,945,000 | – | 792,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,263,408 | $2,843,000 | 0.32% |
| NEA Management Company, LLC | 5,940,796 | $13,367,000 | 0.17% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,824,883 | $10,856,000 | 0.08% |
| WealthTrust Axiom LLC | 39,500 | $88,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 34,600 | $78,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 49,077 | $110,000 | 0.00% |
| BlackRock Inc. | 44,180 | $99,000 | 0.00% |
| LPL Financial LLC | 10,000 | $23,000 | 0.00% |
| Alberta Investment Management Corp | 25,000 | $56,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,187 | $10,000 | 0.00% |